Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells

Tumor Biology

Volumn 34, Issue 1, 2013, Pages 285-291

  Ishii, Terukazu ^a   Kira, Naoko ^a   Yoshida, Toshie ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle; Cucurbitacin D; Endometrial cancer; Ovarian cancer

Indexed keywords

CASPASE 3; CASPASE 9; CUCURBITACIN GLYCOSIDE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROCASPASE 9; PROTEIN BAD; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; M PHASE CELL CYCLE CHECKPOINT; MITOCHONDRIAL MEMBRANE POTENTIAL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84872801614     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0549-2     Document Type: Article

References (18)

1. MJ Reinhardt 2008 Gynecologic tumors Recent Results Cancer Res 170 141 150 18019623 10.1007/978-3-540-31203-1-11 1:STN:280:DC%2BD2snos1Khuw%3D%3D
2. JC Obel G Friberg GF Fleming 2006 Chemotherapy in endometrial cancer Clin Adv Hematol Oncol 4 459 468 16981669
3. WE Winter 3rd GL Maxwell C Tian, et al. 2008 Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a gynecologic oncology group study J Clin Oncol 26 83 89 10.1200/JCO.2007.13.1953 18025437 10.1200/JCO.2007.13.1953
4. B Jayaprakasam NP Seeram MG Nair 2003 Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana Cancer Lett 189 11 16 12445672 10.1016/S0304-3835(02)00497-4 1:CAS:528:DC%2BD38XoslGis7s%3D
5. JC Chen MH Chiu RL Nie, et al. 2005 Cucurbitacins and cucurbitane glycosides: structures and biological activities Nat Prod Rep 22 386 399 10.1039/B418841C 16010347 10.1039/b418841c 1:CAS:528:DC%2BD2MXmtVaku7c%3D
6. N Takahashi Y Yoshida T Sugiura, et al. 2009 Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro Int Immunopharmacol 9 508 513 19185617 10.1016/j.intimp.2009.01. 006 1:CAS:528:DC%2BD1MXjt1Snsb4%3D
7. N Ding U Yamashita H Matsuoka, et al. 2011 Apoptosis induction through proteasome inhibitory activity of cucurbitacin D in human T-cell leukemia Cancer 117 2735 2746 10.1002/cncr.25711 21656752 10.1002/cncr.25711 1:CAS:528:DC%2BC3MXnt1KrtrY%3D
8. G Rimon CE Bazenet KL Philpott, et al. 1997 Increased surface phosphatidylserine is an early marker of neuronal apoptosis J Neurosci Res 48 563 570 10.1002/(SICI)1097-4547 9210526 10.1002/(SICI)1097-4547(19970615)48: 6<563::AID-JNR9>3.0.CO;2-8 1:CAS:528:DyaK2sXkt1eksbo%3D
9. Y Chen DL Kramer P Diegelman, et al. 2001 Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells Cancer Res 61 6437 6444 11522638 1:CAS:528:DC%2BD3MXmsF2jsb4%3D
10. AM Abukhdeir BH Park 2008 P21 and p27: roles in carcinogenesis and drug resistance Expert Rev Mol Med 10 e19 18590585 10.1017/S1462399408000744
11. PN Kelly A Strasser 2011 The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy Cell Death Differ 18 1414 1424 10.1038/cdd.2011.17 21415859 10.1038/cdd.2011.17 1:CAS:528:DC%2BC3MXhtVWnt7rJ
12. DG Johnson CL Walker 1999 Cyclins and cell cycle checkpoints Ann Rev Pharmacol Toxicol 39 295 312 10.1146/annurev.pharmtox.39.1.295 1:CAS:528:DyaK1MXjtVejtL8%3D
13. I Tretiakova D Blaesius L Maxia, et al. 2008 Myrtucommulone from Myrtus communis induces apoptosis in cancer cells via the mitochondrial pathway involving caspase-9 Apoptosis 13 119 131 17955373 10.1007/s10495-007-0150-0 1:CAS:528:DC%2BD1cXjt12gsr0%3D
14. K Liu H Xing S Xhang, et al. 2010 Cucurbitacin D induces fetal hemoglobin synthesis in K562 cells and human hematopoietic progenitors through activation of p38 pathway and stabilization of the γ-globin mRNA Blood Cells Mol Dis 45 269 275 10.1016/j.bcmd.2010.09.004 20926322 10.1016/j.bcmd.2010.09.004 1:CAS:528:DC%2BC3cXhsV2jtLrL
15. MA Blaskovich J Sun A Cantor, et al. 2003 Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice Cancer Res 63 1270 1279 12649187 1:CAS:528:DC%2BD3sXit1Sgtb4%3D
16. J Konopa A Matuszkiewicz M Hrabowska 1974 Cucurbitacines, cytotoxic and antitumor substances from Bryonia alba L. Part II: Biological studies Arzneimittelforschung 24 1741 1743 4480045 1:CAS:528:DyaE2MXhtFyqurs%3D
17. J Konopa J Zielinski A Matuszkiewicz 1974 Cucurbitacins, cytotoxic and antitumor substances from Bryonia alba L. I: isolation and identification Arzneimittelforschung 24 1554 1557 4479761 1:CAS:528:DyaE2MXntVartg%3D%3D
18. CS Park H Lim KJ Han, et al. 2004 Inhibition of nitric oxide generation by 23,24-dihydrocucurbitacin D in mouse peritoneal macrophages J Pharmacol Exp Ther 309 705 710 10.1124/jpet.103.063693 14752064 10.1124/jpet.103.063693 1:CAS:528:DC%2BD2cXjs1ygsr4%3D